- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04787627
Clinical Investigation (Beta) of Power Knee Mainstream - Dynamic
Clinical Investigation (Beta) of Power Knee
Prospective two group cross over investigation, comparing the investigational device (Power Knee, a powered microprocessor controlled prosthetic knee) and subjects prescribed microprocessor prosthetic knee (MPK).
The primary objective was to evaluate the efficacy of the investigational device in reducing exertion during walking compared to passive MPKs. Additionally to evaluate the efficacy of the investigational device in the short and long term compared to passive MPKs and previous versions of the Power Knee, during daily living activities i.e. walking on level ground, in stairs and inclines, rising from and sitting down to a chair as well as performance of gait functions and ease of set up for average to highly active transfemoral/knee disarticulation amputees and Certified Prosthetists/Orthotists (CPOs).
Study Overview
Detailed Description
This is a prospective two group cross-over study, within subject comparison. 3 study visits are planned for amputee subjects, with approximately 2-3 weeks between visits, and an optional fourth visit 8-12 weeks after the third visit. During the first visit subjects will be check for inclusion/exclusion, consented and randomly assigned into two groups and Group 1 (transitioning to the investigational device) will perform functional tests and answer questionnaires on the performance of their current prosthesis to provide baseline information. The Group 1 subjects will be fitted and trained on the investigational device and a recommended prosthetic foot which they will use as their prescribed prosthesis for 2-3 weeks until the second visit, the other half will stay on their prescribed prosthesis until the second visit.
During the second visit the subjects of Group 1 will perform the same functional tests as in the first visit on the investigational device and answer questionnaires on the performance of the investigational device, and then return to their prescribed prosthesis. The Group 2 will perform the same tests/questionnaires on their prescribed prosthesis and then be fitted and trained on the investigational device and use it as their usual prosthesis for 2-3 weeks.
During the third visit all subject will repeat the tests and questionnaires on the prosthesis they are fitted with (Group1 on the prescribed and Group 2 on the investigational device). Subjects will have the option to use the investigational device for an additional 8-12 weeks, those who choose that will be fitted with the investigational device or will stay on it, depending in which they are in at this point. They will be booked for the fourth visit; they will be contacted via telephone 4-5 weeks later and asked to provide feedback on their experience with the device so far. Those that choose not to keep using the investigational device will be returned to their prescribed prosthesis.
During the fourth visit subjects will answer the same questionnaires and perform the same functional tests as the other visits. Data will be collected from the knee on activity. They will then be fitted back to their prescribed prosthesis.
End of study. CPO (Certified Prosthetist Orthotist) subjects will answer a questionnaire on the ease of setup of the investigational device and provide feedback on the ease of setup of gait functions.
Statistical considerations:
Outcomes at each timepoint were visually inspected for normality using histograms and qq-plots, as well as a Shapiro-Wilk Normality Test. If the data were deemed to be normal the hypotheses were tested using a two-tailed, paired, student's t-test. Non-normal data was tested using the Wilcoxon signed-rank test.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Silver Spring, Maryland, United States, 20910
- Medical Center Orthotics and Prosthetics
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02134
- Medical Center Orthotics and Prosthetics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 50Kg< body weight < 116Kg
- K3-K4 amputees with unilateral transfemoral amputation or Knee disarticulation
- Allows for 37mm knee center height to dome of pyramid alignment
- Currently using a MPK or Power Knee
- Older than 18 years old
- No socket issues/changes in the last 6 weeks and no socket changes expected during the duration of the study period.
- Comfortable and stable socket fit
- Willing and able to participate in the study and follow the protocol
Exclusion Criteria:
- 50Kg> body weight > 116Kg
- Bilateral amputees
- Users with socket problems
- Users with co-morbidities in the contra-lateral limb, which affect their functional mobility
- Younger than 18 years old
- Users with stump pain
- Users with cognitive impairment
- Users not involved in other clinical tests and/or receiving treatment that the testing might affect.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Power Knee before prescribed prosthesis
Power Knee, the investigational device is fitted on subjects and they use it as their primary prosthesis for 2 weeks before coming in for data collection on the device.
After being on the investigational device for 2 weeks subjects go back on their prescribed prosthesis for 2 weeks and comparator data is collected.
|
Powered microprocessor controlled prosthetic knee
|
|
Experimental: Power Knee after Prescribed prosthesis
Subjects start the study by using their prescribed prosthesis for 2 weeks, then they come in for data collection of comparator data, in that same visit they are fitted with the investigational device and wear that for 2 weeks before coming in for data collection on that device.
|
Powered microprocessor controlled prosthetic knee
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Difference in Borg Category Rating Scale Before and After 6MWT at 2 Weeks
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Mean difference in perceived exertion on the Borg rating scale of perceived exertion before and after 6 minute walk test (6MWT) (see outcome 2) with investigational device (Power Knee) compared to comparator (prescribed device). Subjects are asked how exerted they feel on a scale of 0-10 (0 indicating no exertion and 10 indicating the most exertion) at rest before they carry out the 6MWT, and after carrying out the 6MWT, the difference is recorded. The Borg Category Rating 10 scale (CR10) is a validated measure of perceived exertion. |
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Average Distance Walked in 6 Minute Walk Test
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Average distance walked in 6MWT with investigational device (Power Knee) compared to comparator (prescribed device) User walk for 6 minutes in their self selected walking speed on a 30 meter track. Shorter time indicates better mobility performance. |
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Score of Prosthesis Mobility Questionnaire (PMQ) Questions 9 and 10
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Support in sit to stand and stand to sit evaluation: Total score (minimum score 0 - maximum score 8) of Prosthetic Mobility Questionnaire (PMQ) questions 9 and 10 with investigational device (Power Knee) compared to comparator (prescribed knee): PMQ : Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis (0=no ability, 4=fully able):
The total score is obtained by summing the scores from questions 9 and 10. |
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Average Score of Modified Prosthesis Evaluation Questionnaire (PEQ) Question 14F
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Average score with investigational device (Power Knee) compared to comparator (prescribed device) of modified PEQ Question 14F Modified PEQ question 14F : Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis : • Question 14F. Your safety when walking down a steep hill using the prosthesis The scale used is a Likert Scale 1-10 (1 indicating low rating of safety and 10 indicating a high rating of safety). |
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Average Score of Modified Prosthesis Evaluation Questionnaire (PEQ) Question 13D
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Average score with investigational device (Power Knee) compared to comparator (prescribed device) of modified PEQ Question 13D Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis : • Question 13D.Your safety when walking downstairs using the prosthesis The scale used is a Likert Scale 1-10 (1 indicating low rating of safety and 10 indicating a high rating of safety). |
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Satisfaction With Walking Speed
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Proportion of subjects reporting satisfaction with walking speed on investigational device
|
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Prosthetic Limb Users Survey of Mobility (PLUS-M) T-score
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Ability to ambulate over typical environmental obstacles measured by the Prosthetic Limb Users Survey of Mobility (PLUS-M), T-score with Power Knee compared to comparator (prescribed device). The Prosthetic Limb Users Survey of Mobility™ is a self-report instrument for measuring mobility of adults with lower limb amputation. Scoring a PLUS-M short form produces a T-score. To find the T-score, the scores must be summed for all responses on the short form (creating a raw score). Then the raw score needs to be used to determine the T-score in the conversation table provided with the PLUS-M questionnaire. The T-score is a standardized score with a mean of 50 and a standard deviation of 10. A higher T-score indicates a higher level of mobility. The highest possible T-score is 71.4 and the lowest one is 21.8. |
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Average Score of Modified Prosthesis Evaluation Questionnaire (PEQ) Question 13A
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Average score with investigational device (Power Knee) compared to comparator (prescribed device) of modified PEQ Question 13A Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis : • Question 13A. Your safety (during stance phase) when walking with your prosthesis (prescribed device) /test prosthesis (Power Knee)? The scale used is a Likert Scale 1-10 (1 indicating low rating of safety and 10 indicating a high rating of safety). |
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Average Score of Prosthesis Evaluation Questionnaire (PEQ) Question 1D
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Average score with investigational device (Power Knee) compared to comparator (prescribed device) of modified PEQ Question 1D Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis : • Question 1D. Your comfort while standing when using your prosthesis/test prosthesis? The scale used is a Likert Scale 1-10 (1 indicating low rating of safety and 10 indicating a high rating of safety). |
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Average Score Regarding the Ease of Setup
Time Frame: Immediately after the intervention (fitting of the investigational device)
|
Self reported ease of setup of investigational device compared to state of the art microprocessor knees (SOTA MPKs) and previous version of the investigational device. Average score with investigational device (Power Knee) compared to comparator (previous version of Power Knee) and compared to state of the art microprocessor knees (SOTA MPKs) The scale used is a Likert Scale 1-10 (1 indicating low rating and 10 indicating a high rating). |
Immediately after the intervention (fitting of the investigational device)
|
|
Proportion of Participants With Average Score Over 5 on Questions 3K and 3L of the Prosthesis Evaluation Questionnaire (PEQ) With the Investigational Device
Time Frame: After 2 weeks of either using the Power Knee or their own prescribed knee
|
Proportion of participants with Average score with investigational device of PEQ questions 3K and 3L over 5 PEQ- Questions 3K, 3L:
Support question (yes/no) "Would the noise from the test device prevent you from preferring it as your usual prosthesis?" |
After 2 weeks of either using the Power Knee or their own prescribed knee
|
|
Total Score of Prosthesis Mobility Questionnaire (PMQ) Questions 1 and 3-6:
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Total score of PMQ questions 1,3-6 (minimum score 0 - maximum score 20): PMQ (Questions 1 and 3-6): Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis:
|
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Time Required to Complete the L-test
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
The L-Test of Functional Mobility consists of a series of movements designed to assess an individual's physical function and dynamic balance.
The test involves the participant starting from a seated position, standing up, walking a short distance, turning, walking back, and returning to the seated position.
The course typically forms an "L" shape, which includes two turns, and the total distance covered is longer than that of similar tests like the Timed Up and Go (TUG) test.
The outcome measure is the time taken to complete these movements, providing an objective evaluation of the participant's functional mobility.
There is no fixed minimum or maximum; lower times indicate better performance (i.e., faster completion reflects greater mobility).
|
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Average Prosthetic Mobility Questionnaire (PMQ) Total Score
Time Frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
Average Prosthetic Mobility Questionnaire (PMQ) total score (minimum score 0 - maximum score 48) with investigational device (Power Knee) compared to comparator (prescribed device). The Prosthetic Mobility Questionnaire is a tool for assessing mobility in people with lower-limb amputation, higher score indicates better mobility performance. |
At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
|
|
Occurrence of Side Effects That Could be Directly Related to Using the Power Knee
Time Frame: After 2 weeks of using the Power Knee
|
Evaluating the occurrence of side effects associated with the Power Knee entails systematically documenting and analyzing any adverse effects experienced by users throughout the 2 weeks of use.
|
After 2 weeks of using the Power Knee
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ian Fothergill, CPO, Medical Center Orthotics and Prosthetics (MCOP) Silver Spring
- Principal Investigator: John Warren, CPO, Medical Center Orthotics and Prosthetics (MCOP) Boston
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CIP2019050213
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amputation
-
Shirley Ryan AbilityLabUniversity of AlbertaActive, not recruitingAmputation | Amputation; Traumatic, Hand | Amputation, Traumatic | Amputation; Traumatic, LimbUnited States
-
Liberating Technologies, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAmputation | Prosthesis User | Amputation; Traumatic, Hand | Amputation, CongenitalUnited States
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAmputation | Amputation; Traumatic, Limb | Upper Limb Amputation at the Hand | Upper Limb Amputation at the WristUnited States
-
Medipol UniversityRecruitingEvaluation of Functionality of Amputees According to the Medicare Functional K Classification SystemAmputation | Amputation; Traumatic, Leg, LowerTurkey
-
Point DesignsEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingAmputation; Traumatic, Hand | Amputation, CongenitalUnited States
-
Shirley Ryan AbilityLabRecruitingAmputation | Amputation, Traumatic | Amputation; Traumatic, Limb | Amputation of KneeUnited States
-
Fondazione Don Carlo Gnocchi OnlusCompletedAmputation | Amputation; Traumatic, Leg, LowerItaly
-
Fondazione Don Carlo Gnocchi OnlusCompletedAmputation | Amputation; Traumatic, Leg, LowerItaly
-
Hacettepe UniversityCompleted
-
Boninger, Michael, MDNational Institute of Neurological Disorders and Stroke (NINDS); Ripple Therapeutics...RecruitingAmputation | Amputation; Traumatic, HandUnited States
Clinical Trials on Power Knee
-
Liberating Technologies, Inc.Hanger Clinic: Prosthetics & OrthoticsCompletedLower Limb Amputation Above Knee (Injury) | Amputation | Prosthesis User | Amputation; Traumatic, Leg, Lower | Limb; Absence, Congenital, Lower | Amputation; Traumatic, Leg: Thigh, Between Hip and KneeUnited States
-
Liberating Technologies, Inc.Hanger Clinic: Prosthetics & OrthoticsRecruitingLower Limb Amputation Above Knee (Injury) | Amputation | Prosthesis User | Amputation; Traumatic, Leg, Lower | Limb; Absence, Congenital, Lower | Amputation; Traumatic, Leg: Thigh, Between Hip and KneeUnited States
-
Össur Iceland ehfTerminatedAmputation | Transfemoral AmputationUnited States
-
University of WashingtonÖssur EhfCompletedTransfemoral AmputationUnited States
-
Össur Iceland ehfUniversity of IcelandActive, not recruitingFall Prevention | Balance, Falls | Amputation of Lower LimbIceland
-
Loma Linda UniversityÖssur Iceland ehfRecruitingTransfemoral AmputationUnited States
-
Georgia Institute of TechnologyCompleted
-
Össur EhfCompletedAmputation | Prosthesis UserGermany, Iceland
-
YourResearchProject Pty LtdÖssur EhfRecruitingAmputation | Prosthesis UserAustralia
-
University of OklahomaU.S. Department of EducationCompletedCerebral Palsy | Child, PreschoolUnited States